Table 2 General features of the studies
Studies | No of patients with DM assigned to the polymer free amphilimus-eluting stents (n) | No of patients with DM assigned to the durable polymer zotarolimus eluting stents (n) | Type of study | Bias risk grade |
|---|---|---|---|---|
Hemert 2020 | 150 | 153 | Trial | B |
Romaguera 2022 | 565 | 557 | Trial | B |
Rozemeijer 2017 | 85 | 80 | Observational | B |
Rozemeijer 2018 | 112 | 93 | Observational | B |
Total no of patients (n) | 912 | 883 |